Millennium Management’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
Other funds holding CCCC
RCM
LCM
SCM
BCLSI
Millennium Management's CCCC Position: Q2 2026 in Review
Millennium Management reduced its C4 Therapeutics (CCCC) stake by 85% in Q2 2026, selling an estimated $4.03M and leaving 215,386 shares worth $1.01M. The position accounts for ﹤0.01% of the portfolio, ranked #4309.
Millennium Management first reported a position in CCCC in Q4 2020 and has held it in 21 quarters since. The position peaked at $24.3M in Q4 2021. 148 funds tracked by Wall St. Rank hold CCCC as of Q2 2026.
- Millennium Management held 215,386 shares of C4 Therapeutics worth $1.01M as of Q2 2026.
- Millennium Management sold 1,177,956 C4 Therapeutics shares in Q2 2026, an estimated $4.03M.
- C4 Therapeutics made up ﹤0.01% of Millennium Management's portfolio in Q2 2026, its #4309 holding.
- Millennium Management first reported a position in C4 Therapeutics in Q4 2020 and has held it in 21 quarters since.
- Millennium Management's C4 Therapeutics position peaked at $24.3M in Q4 2021.
- 148 funds tracked by Wall St. Rank held C4 Therapeutics as of Q2 2026.
Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.